HISTRELIN | HISTRELIN | ATC H01CA03 ATC L02AE05
GONADOTROPIN RELEASING HORMONE (GNRH) AGONIST HORMONES TREATMENT OF ADVANCED PROSTATE CANCER INHIBITOR OF GONADOTROPIN SECRETION TRANSIENT INCREASE IN CONCENTRATION OF GONADAL STEROIDS (TESTOSTERONE AND DIHYDROTESTOSTERONE IN MALES) TREATMENT OF PRECOCIOUS PUBERTY | INJECTION SUBCUTANEOUS | Cmax 0.83 NANOMOLAR F 92 PERCENT VD 58.4 LITER PPB 70.5 PERCENT Cl 10.7 LITER / HOUR HT 3.92 HOUR | GONADOTROPIN-RELEASING HORMONE RECEPTOR | GONADOTROPIN-RELEASING HORMONE RECEPTOR AGONIST CHEMBL1855 GONADOTROPIN-RELEASING HORMONE RECEPTOR P30968 GONADOTROPIN-RELEASING HORMONE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 PEPTIDE SHORT PEPTIDE GNRH RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |